IDEAYA Biosciences, Inc. (IDYA)

IDEAYA Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 11, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,816	2,221	2,293	874	910	407
Market Cap Growth	37.93%	-3.15%	162.34%	-3.92%	123.69%	168.50%
Enterprise Value	1,706	1,040	1,784	484	530	125
Last Close Price	33.25	25.70	35.58	18.17	23.64	14.00
PS Ratio	13.65	317.33	98.07	17.17	32.57	20.82
PB Ratio	2.67	2.10	3.69	2.50	3.02	2.05
P/TBV Ratio	2.58	2.10	3.69	2.50	3.02	2.05
P/FCF Ratio	-	-	-	-	-	7.40
P/OCF Ratio	-	-	-	-	-	7.33
EV/Sales Ratio	7.94	148.56	76.31	9.51	18.96	6.40
EV/FCF Ratio	-	-	-	-	-	2.27
Debt / Equity Ratio	0.03	0.02	0.01	0.01	0.02	0.03
Debt / FCF Ratio	-	-	-	-	-	0.12
Asset Turnover	0.18	0.01	0.05	0.13	0.08	0.10
Quick Ratio	12.20	14.68	19.38	11.51	5.49	7.39
Current Ratio	12.44	14.97	19.65	11.68	5.56	7.47
Return on Equity (ROE)	-14.15%	-32.67%	-23.28%	-18.02%	-19.91%	-23.10%
Return on Assets (ROA)	-10.77%	-23.05%	-16.20%	-10.15%	-9.25%	-10.74%
Return on Capital Employed (ROCE)	-18.60%	-30.30%	-21.60%	-17.50%	-15.00%	-13.60%
Earnings Yield	-5.71%	-12.36%	-4.92%	-6.71%	-5.47%	-8.48%
FCF Yield	-3.74%	-11.32%	-5.13%	-10.37%	-6.42%	13.51%
Buyback Yield / Dilution	-15.78%	-42.00%	-38.79%	-17.57%	-42.60%	-97.82%

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q